HighTower Advisors LLC Buys 4,987 Shares of HCA Healthcare, Inc. $HCA

HighTower Advisors LLC grew its stake in shares of HCA Healthcare, Inc. (NYSE:HCA) by 14.5% during the 4th quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The fund owned 39,390 shares of the company’s stock after buying an additional 4,987 shares during the period. HighTower Advisors LLC’s holdings in HCA Healthcare were worth $18,389,000 as of its most recent filing with the Securities and Exchange Commission (SEC).

Several other large investors also recently bought and sold shares of the business. Mission Wealth Management LP increased its position in HCA Healthcare by 1.9% in the fourth quarter. Mission Wealth Management LP now owns 2,606 shares of the company’s stock worth $1,217,000 after purchasing an additional 48 shares during the last quarter. Gamco Investors INC. ET AL increased its position in HCA Healthcare by 1.0% in the fourth quarter. Gamco Investors INC. ET AL now owns 29,084 shares of the company’s stock worth $13,578,000 after purchasing an additional 300 shares during the last quarter. Dougherty & Associates LLC bought a new stake in HCA Healthcare in the fourth quarter worth $521,000. North Dakota State Investment Board bought a new stake in HCA Healthcare in the fourth quarter worth $2,739,000. Finally, Elyxium Wealth LLC bought a new stake in HCA Healthcare in the fourth quarter worth $222,000. Institutional investors own 62.73% of the company’s stock.

Wall Street Analyst Weigh In

Several research analysts have commented on the stock. KeyCorp dropped their price objective on shares of HCA Healthcare from $550.00 to $510.00 and set an “overweight” rating for the company in a research note on Monday, April 27th. Argus dropped their price objective on shares of HCA Healthcare from $560.00 to $500.00 and set a “buy” rating for the company in a research note on Monday, May 4th. JPMorgan Chase & Co. dropped their price objective on shares of HCA Healthcare from $535.00 to $490.00 and set a “neutral” rating for the company in a research note on Tuesday, May 19th. Sanford C. Bernstein dropped their price objective on shares of HCA Healthcare from $541.00 to $503.00 and set a “market perform” rating for the company in a research note on Tuesday, April 28th. Finally, UBS Group lifted their price objective on shares of HCA Healthcare from $598.00 to $635.00 and gave the stock a “buy” rating in a research note on Monday, February 23rd. Sixteen analysts have rated the stock with a Buy rating, seven have assigned a Hold rating and one has assigned a Sell rating to the company’s stock. According to MarketBeat, the stock has a consensus rating of “Moderate Buy” and an average target price of $515.77.

HCA Healthcare Price Performance

NYSE:HCA opened at $394.40 on Friday. HCA Healthcare, Inc. has a 1-year low of $330.00 and a 1-year high of $556.52. The company has a 50-day moving average of $465.16 and a 200 day moving average of $483.61. The firm has a market cap of $87.49 billion, a PE ratio of 13.56, a price-to-earnings-growth ratio of 1.25 and a beta of 1.18.

HCA Healthcare (NYSE:HCA) last announced its earnings results on Friday, April 24th. The company reported $7.15 EPS for the quarter, missing analysts’ consensus estimates of $7.19 by ($0.04). The firm had revenue of $19.11 billion during the quarter, compared to the consensus estimate of $19.09 billion. HCA Healthcare had a negative return on equity of 295.93% and a net margin of 8.89%.The business’s revenue for the quarter was up 4.3% compared to the same quarter last year. During the same quarter in the prior year, the firm posted $6.45 earnings per share. HCA Healthcare has set its FY 2026 guidance at 29.100-31.500 EPS. Sell-side analysts anticipate that HCA Healthcare, Inc. will post 30.07 EPS for the current fiscal year.

HCA Healthcare Dividend Announcement

The company also recently announced a quarterly dividend, which will be paid on Tuesday, June 30th. Shareholders of record on Tuesday, June 16th will be issued a $0.78 dividend. The ex-dividend date is Tuesday, June 16th. This represents a $3.12 dividend on an annualized basis and a yield of 0.8%. HCA Healthcare’s payout ratio is currently 10.73%.

HCA Healthcare Company Profile

HCA Healthcare is a for‑profit operator of healthcare facilities headquartered in Nashville, Tennessee. Founded in 1968, the company owns and operates a network of hospitals and related healthcare facilities and has grown through organic expansion and acquisitions to become a large provider of inpatient and outpatient services.

The company’s core activities include the operation of acute care hospitals, freestanding surgical and emergency centers, and outpatient clinics. HCA’s services encompass inpatient care, surgical services, emergency medicine, diagnostic imaging and laboratory testing, and various outpatient and ambulatory care offerings.